Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Cytokine Network and Sexual HIV Transmission in Men Who Have Sex With Men.

Vanpouille C, Frick A, Rawlings SA, Hoenigl M, Lisco A, Margolis L, Gianella S.

Clin Infect Dis. 2019 Nov 26. pii: ciz1150. doi: 10.1093/cid/ciz1150. [Epub ahead of print]

PMID:
31768525
2.

Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.

Dimitrova D, Gea-Banacloche J, Steinberg SM, Sadler JL, Hicks SN, Carroll E, Wilder JS, Parta M, Skeffington L, Hughes TE, Blau JE, Broadney MM, Rose JJ, Hsu AP, Fletcher R, Nunes NS, Yan XY, Telford WG, Kapoor V, Cohen JI, Freeman AF, Garabedian E, Holland SM, Lisco A, Malech HL, Notarangelo LD, Sereti I, Shah NN, Uzel G, Zerbe CS, Fowler DH, Gress RE, Kanakry CG, Kanakry JA.

Biol Blood Marrow Transplant. 2019 Sep 4. pii: S1083-8791(19)30558-0. doi: 10.1016/j.bbmt.2019.08.018. [Epub ahead of print]

PMID:
31493539
3.

Corrigendum: Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS).

Lisco A, Wong CS, Price S, Ye P, Niemela J, Anderson M, Richards E, Manion M, Mystakelis H, Similuk M, Lo B, Stoddard J, Rosenzweig S, Vanpouille C, Rupert A, Maric I, Perez-Diez A, Parenti D, Burbelo PD, Rao VK, Sereti I.

Front Immunol. 2019 Jul 4;10:1552. doi: 10.3389/fimmu.2019.01552. eCollection 2019.

4.

Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS).

Lisco A, Wong CS, Price S, Ye P, Niemela J, Anderson M, Richards E, Manion M, Mystakelis H, Similuk M, Lo B, Stoddard J, Rosenzweig S, Vanpouille C, Rupert A, Maric I, Perez-Diez A, Parenti D, Burbelo PD, Rao VK, Sereti I.

Front Immunol. 2019 May 29;10:1193. doi: 10.3389/fimmu.2019.01193. eCollection 2019. Erratum in: Front Immunol. 2019 Jul 04;10:1552.

5.

IRIS as a post-transplantation complication in primary immunodeficiency with disseminated M. avium.

Manion M, Dimitrova D, Pei L, Gea-Banacloche J, Zelazny A, Lisco A, Zerbe C, Freeman AF, Holland SM, Kanakry CG, Kanakry JA, Sereti I.

Clin Infect Dis. 2019 Jun 12. pii: ciz507. doi: 10.1093/cid/ciz507. [Epub ahead of print]

PMID:
31190050
6.

Identification of rare HIV-1-infected patients with extreme CD4+ T cell decline despite ART-mediated viral suppression.

Lisco A, Wong CS, Lage SL, Levy I, Brophy J, Lennox J, Manion M, Anderson MV, Mejia Y, Grivas C, Mystakelis H, Burbelo PD, Perez-Diez A, Rupert A, Martens CA, Anzick SL, Morse C, Chan S, Deleage C, Sereti I.

JCI Insight. 2019 Apr 18;4(8). pii: 127113. doi: 10.1172/jci.insight.127113. eCollection 2019 Apr 18.

7.

Emergence of Kaposi's Sarcoma Herpesvirus-Associated Complications Following Corticosteroid Use in TB-IRIS.

Manion M, Uldrick T, Polizzotto MN, Sheikh V, Roby G, Lurain K, Metzger D, Mican JM, Pau A, Lisco A, Laidlaw E, Hammoud DA, Whitby D, Yarchoan R, Sereti I.

Open Forum Infect Dis. 2018 Oct 12;5(10):ofy217. doi: 10.1093/ofid/ofy217. eCollection 2018 Oct.

8.

Metagenomic Discovery of 83 New Human Papillomavirus Types in Patients with Immunodeficiency.

Pastrana DV, Peretti A, Welch NL, Borgogna C, Olivero C, Badolato R, Notarangelo LD, Gariglio M, FitzGerald PC, McIntosh CE, Reeves J, Starrett GJ, Bliskovsky V, Velez D, Brownell I, Yarchoan R, Wyvill KM, Uldrick TS, Maldarelli F, Lisco A, Sereti I, Gonzalez CM, Androphy EJ, McBride AA, Van Doorslaer K, Garcia F, Dvoretzky I, Liu JS, Han J, Murphy PM, McDermott DH, Buck CB.

mSphere. 2018 Dec 12;3(6). pii: e00645-18. doi: 10.1128/mSphereDirect.00645-18.

9.

Hallmarks of primate lentiviral immunodeficiency infection recapitulate loss of innate lymphoid cells.

Mudd JC, Busman-Sahay K, DiNapoli SR, Lai S, Sheik V, Lisco A, Deleage C, Richardson B, Palesch DJ, Paiardini M, Cameron M, Sereti I, Reeves RK, Estes JD, Brenchley JM.

Nat Commun. 2018 Sep 27;9(1):3967. doi: 10.1038/s41467-018-05528-3.

10.

Increased Metabolic Activity on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Human Immunodeficiency Virus-Associated Immune Reconstitution Inflammatory Syndrome.

Hammoud DA, Boulougoura A, Papadakis GZ, Wang J, Dodd LE, Rupert A, Higgins J, Roby G, Metzger D, Laidlaw E, Mican JM, Pau A, Lage S, Wong CS, Lisco A, Manion M, Sheikh V, Millo C, Sereti I.

Clin Infect Dis. 2019 Jan 7;68(2):229-238. doi: 10.1093/cid/ciy454.

11.

Cytomegalovirus and HIV Persistence: Pouring Gas on the Fire.

Christensen-Quick A, Vanpouille C, Lisco A, Gianella S.

AIDS Res Hum Retroviruses. 2017 Nov;33(S1):S23-S30. doi: 10.1089/aid.2017.0145. Review.

12.

A common anti-cytomegalovirus drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo.

Vanpouille C, Bernatchez JA, Lisco A, Arakelyan A, Saba E, Götte M, Margolis L.

AIDS. 2017 Jul 17;31(11):1519-1528. doi: 10.1097/QAD.0000000000001532.

13.

Susceptibility to Cryptococcal Meningoencephalitis Associated With Idiopathic CD4+ Lymphopenia and Secondary Germline or Acquired Defects.

Panackal AA, Rosen LB, Uzel G, Davis MJ, Hu G, Adeyemo A, Tekola-Ayele F, Lisco A, Diachok C, Kim JD, Shaw D, Sereti I, Stoddard J, Niemela J, Rosenzweig SD, Bennett JE, Williamson PR.

Open Forum Infect Dis. 2017 Jun 7;4(2):ofx082. doi: 10.1093/ofid/ofx082. eCollection 2017 Spring.

14.

Interleukin-12 and Interleukin-23 Blockade in Leukocyte Adhesion Deficiency Type 1.

Moutsopoulos NM, Zerbe CS, Wild T, Dutzan N, Brenchley L, DiPasquale G, Uzel G, Axelrod KC, Lisco A, Notarangelo LD, Hajishengallis G, Notarangelo LD, Holland SM.

N Engl J Med. 2017 Mar 23;376(12):1141-1146. doi: 10.1056/NEJMoa1612197.

15.

HIV Trafficking Between Blood and Semen During Early Untreated HIV Infection.

Chaillon A, Smith DM, Vanpouille C, Lisco A, Jordan P, Caballero G, Vargas M, Gianella S, Mehta SR.

J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):95-102.

16.

Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the Literature.

Zerbe CS, Marciano BE, Katial RK, Santos CB, Adamo N, Hsu AP, Hanks ME, Darnell DN, Quezado MM, Frein C, Barnhart LA, Anderson VL, Uzel G, Freeman AF, Lisco A, Nath A, Major EO, Sampaio EP, Holland SM.

Clin Infect Dis. 2016 Apr 15;62(8):986-94. doi: 10.1093/cid/civ1220. Epub 2016 Jan 6. Review.

17.

Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection.

Vanpouille C, Introini A, Morris SR, Margolis L, Daar ES, Dube MP, Little SJ, Smith DM, Lisco A, Gianella S.

AIDS. 2016 Jan;30(2):193-201. doi: 10.1097/QAD.0000000000000964.

18.

Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men.

Gianella S, Smith DM, Daar ES, Dube MP, Lisco A, Vanpouille C, Margolis L, Haubrich RH, Morris SR.

PLoS One. 2015 Jun 10;10(6):e0130410. doi: 10.1371/journal.pone.0130410. eCollection 2015.

19.

Valacyclovir Decreases Plasma HIV-1 RNA in HSV-2 Seronegative Individuals: A Randomized Placebo-Controlled Crossover Trial.

Vanpouille C, Lisco A, Grivel JC, Bassit LC, Kauffman RC, Sanchez J, Schinazi RF, Lederman MM, Rodriguez B, Margolis L.

Clin Infect Dis. 2015 Jun 1;60(11):1708-14. doi: 10.1093/cid/civ172. Epub 2015 Mar 3.

20.

Interleukin-7 facilitates HIV-1 transmission to cervico-vaginal tissue ex vivo.

Introini A, Vanpouille C, Lisco A, Grivel JC, Margolis L.

PLoS Pathog. 2013 Feb;9(2):e1003148. doi: 10.1371/journal.ppat.1003148. Epub 2013 Feb 7.

21.

Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle.

Saba E, Origoni M, Taccagni G, Ferrari D, Doglioni C, Nava A, Lisco A, Grivel JC, Margolis L, Poli G.

Mucosal Immunol. 2013 Nov;6(6):1081-90. doi: 10.1038/mi.2013.2. Epub 2013 Feb 6.

22.

HIV-1 imposes rigidity on blood and semen cytokine networks.

Lisco A, Introini A, Munawwar A, Vanpouille C, Grivel JC, Blank P, Singh S, Margolis L.

Am J Reprod Immunol. 2012 Dec;68(6):515-21. doi: 10.1111/aji.12015. Epub 2012 Sep 24.

23.

Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin.

Vanpouille C, Lisco A, Introini A, Grivel JC, Munawwar A, Merbah M, Schinazi RF, Derudas M, McGuigan C, Balzarini J, Margolis L.

Antimicrob Agents Chemother. 2012 May;56(5):2604-11. doi: 10.1128/AAC.05986-11. Epub 2012 Feb 6.

24.

Semen of HIV-1-infected individuals: local shedding of herpesviruses and reprogrammed cytokine network.

Lisco A, Munawwar A, Introini A, Vanpouille C, Saba E, Feng X, Grivel JC, Singh S, Margolis L.

J Infect Dis. 2012 Jan 1;205(1):97-105. doi: 10.1093/infdis/jir700. Epub 2011 Nov 22.

25.

Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication.

Andrei G, Lisco A, Vanpouille C, Introini A, Balestra E, van den Oord J, Cihlar T, Perno CF, Snoeck R, Margolis L, Balzarini J.

Cell Host Microbe. 2011 Oct 20;10(4):379-89. doi: 10.1016/j.chom.2011.08.015.

26.

Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection.

Merbah M, Introini A, Fitzgerald W, Grivel JC, Lisco A, Vanpouille C, Margolis L.

Am J Reprod Immunol. 2011 Mar;65(3):268-78. doi: 10.1111/j.1600-0897.2010.00967.x. Epub 2011 Jan 12.

27.

Contrasting roles for TLR ligands in HIV-1 pathogenesis.

Brichacek B, Vanpouille C, Kiselyeva Y, Biancotto A, Merbah M, Hirsch I, Lisco A, Grivel JC, Margolis L.

PLoS One. 2010 Sep 20;5(9). pii: e12831. doi: 10.1371/journal.pone.0012831.

28.

HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model.

Saba E, Grivel JC, Vanpouille C, Brichacek B, Fitzgerald W, Margolis L, Lisco A.

Mucosal Immunol. 2010 May;3(3):280-90. doi: 10.1038/mi.2010.2. Epub 2010 Feb 10.

29.

A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.

Vanpouille C, Lisco A, Derudas M, Saba E, Grivel JC, Brichacek B, Scrimieri F, Schinazi R, Schols D, McGuigan C, Balzarini J, Margolis L.

J Infect Dis. 2010 Feb 15;201(4):635-43. doi: 10.1086/650343.

30.

CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission.

Lim JK, McDermott DH, Lisco A, Foster GA, Krysztof D, Follmann D, Stramer SL, Murphy PM.

J Infect Dis. 2010 Jan 15;201(2):178-85. doi: 10.1086/649426.

31.

War and peace between microbes: HIV-1 interactions with coinfecting viruses.

Lisco A, Vanpouille C, Margolis L.

Cell Host Microbe. 2009 Nov 19;6(5):403-8. doi: 10.1016/j.chom.2009.10.010. Review.

32.

Acyclovir: a new use for an old drug.

Vanpouille C, Lisco A, Margolis L.

Curr Opin Infect Dis. 2009 Dec;22(6):583-7. doi: 10.1097/QCO.0b013e32833229b8. Review.

PMID:
19726982
33.

A missed point in deciphering the viral synergy between herpes simplex virus and HIV.

Lisco A, Vanpouille C, Margolis L.

Lancet Infect Dis. 2009 Sep;9(9):522-3. doi: 10.1016/S1473-3099(09)70209-9. No abstract available.

34.

The application of phosphoramidate protide technology to acyclovir confers anti-HIV inhibition.

Derudas M, Carta D, Brancale A, Vanpouille C, Lisco A, Margolis L, Balzarini J, McGuigan C.

J Med Chem. 2009 Sep 10;52(17):5520-30. doi: 10.1021/jm9007856.

35.

Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A.

Biancotto A, Grivel JC, Lisco A, Vanpouille C, Markham PD, Gallo RC, Margolis LB, Lusso P.

Retrovirology. 2009 Jul 2;6:61. doi: 10.1186/1742-4690-6-61.

36.

Mechanisms associated with HIV-1 resistance to acyclovir by the V75I mutation in reverse transcriptase.

Tchesnokov EP, Obikhod A, Massud I, Lisco A, Vanpouille C, Brichacek B, Balzarini J, McGuigan C, Derudas M, Margolis L, Schinazi RF, Götte M.

J Biol Chem. 2009 Aug 7;284(32):21496-504. doi: 10.1074/jbc.M109.024026. Epub 2009 Jun 9.

37.

Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man.

Lim JK, Lisco A, McDermott DH, Huynh L, Ward JM, Johnson B, Johnson H, Pape J, Foster GA, Krysztof D, Follmann D, Stramer SL, Margolis LB, Murphy PM.

PLoS Pathog. 2009 Feb;5(2):e1000321. doi: 10.1371/journal.ppat.1000321. Epub 2009 Feb 27.

38.

Integrating integrins into HIV pathogenesis.

Lisco A, Margolis L.

Blood. 2009 Feb 5;113(6):1207-8. doi: 10.1182/blood-2008-11-187146. No abstract available.

PMID:
19196869
39.

Coinfecting viruses as determinants of HIV disease.

Lisco A, Vanpouille C, Margolis L.

Curr HIV/AIDS Rep. 2009 Feb;6(1):5-12. Review.

40.

A highly sensitive and dynamic immunofluorescent cytometric bead assay for the detection of HIV-1 p24.

Biancotto A, Brichacek B, Chen SS, Fitzgerald W, Lisco A, Vanpouille C, Margolis L, Grivel JC.

J Virol Methods. 2009 Apr;157(1):98-101. doi: 10.1016/j.jviromet.2008.11.013. Epub 2009 Jan 6.

41.

Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues.

Lisco A, Vanpouille C, Tchesnokov EP, Grivel JC, Biancotto A, Brichacek B, Elliott J, Fromentin E, Shattock R, Anton P, Gorelick R, Balzarini J, McGuigan C, Derudas M, Götte M, Schinazi RF, Margolis L.

Cell Host Microbe. 2008 Sep 11;4(3):260-270. doi: 10.1016/j.chom.2008.07.008.

42.

HSV-2 suppression and the incidence of HIV.

Lisco A, Vanpouille C.

N Engl J Med. 2008 Jul 31;359(5):535; author reply 535. doi: 10.1056/NEJMc081075. No abstract available.

PMID:
18669436
43.

[Quality of nursing care and assessment: preliminary results of a study performed at the IRCCS "Giovanni Paolo II" Cancer Institute, Bari].

Longo M, Rinaldi M, Pacifico C, Roppo N, Dodaro S, Lisco A; Gruppo di Lavoro.

Prof Inferm. 2008 Jan-Mar;61(1):14-20. Italian.

PMID:
18462568
44.

Upregulation of human cytomegalovirus by HIV type 1 in human lymphoid tissue ex vivo.

Biancotto A, Iglehart SJ, Lisco A, Vanpouille C, Grivel JC, Lurain NS, Reichelderfer PS, Margolis LB.

AIDS Res Hum Retroviruses. 2008 Mar;24(3):453-62. doi: 10.1089/aid.2007.0155.

PMID:
18327985
45.

HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo.

Biancotto A, Iglehart SJ, Vanpouille C, Condack CE, Lisco A, Ruecker E, Hirsch I, Margolis LB, Grivel JC.

Blood. 2008 Jan 15;111(2):699-704. Epub 2007 Oct 1.

46.

Interactions between human immunodeficiency virus type 1 and vaccinia virus in human lymphoid tissue ex vivo.

Vanpouille C, Biancotto A, Lisco A, Brichacek B.

J Virol. 2007 Nov;81(22):12458-64. Epub 2007 Sep 5.

47.

Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor down-modulating activity.

Vermeire K, Lisco A, Grivel JC, Scarbrough E, Dey K, Duffy N, Margolis L, Bell TW, Schols D.

Biochem Pharmacol. 2007 Aug 15;74(4):566-78. Epub 2007 May 29.

PMID:
17603023
48.

HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.

Grivel JC, Elliott J, Lisco A, Biancotto A, Condack C, Shattock RJ, McGowan I, Margolis L, Anton P.

AIDS. 2007 Jun 19;21(10):1263-72.

PMID:
17545702
49.

Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.

Biancotto A, Grivel JC, Iglehart SJ, Vanpouille C, Lisco A, Sieg SF, Debernardo R, Garate K, Rodriguez B, Margolis LB, Lederman MM.

Blood. 2007 May 15;109(10):4272-9. Epub 2007 Feb 8.

50.

Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.

Lisco A, Grivel JC, Biancotto A, Vanpouille C, Origgi F, Malnati MS, Schols D, Lusso P, Margolis LB.

J Virol. 2007 Jan;81(2):708-17. Epub 2006 Oct 25.

Supplemental Content

Support Center